Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer Group.

Brandão M, Prisciandaro E, Xenophontos E, Mariolo A, Sadeghi AH, Filippi AR, Levy A, Bandura A, Caramella C, Dickhoff C, de Margerie-Mellon C, Faivre-Finn C, Portik D, Sanchez-Lorente D, De Ruysscher D, Smit E, Gobbini E, Fadel E, Ruffini E, Olmetto E, Cortiula F, Bahce I, Houda I, Opitz I, Naidoo J, Edwards J, Remon J, Benitez JC, Trujillo JC, Derks J, Amrane K, Hartemink KJ, Stathopoulos K, Hendriks LEL, Iglesias M, Occhipinti M, Guckenberger M, Giaj Levra N, Girard N, Reguart N, Mercier O, Bironzo P, Hofman P, Petersen RH, De Angelis R, Abgral R, Terrisse S, Popat S, Pierret T, Blum TG, Ricardi U, Dionisi V, Berghmans T, Dingemans AC, European Organisation for Research, Treatment of Cancer EORTC Lung Cancer Group

Open source

DOI
10.1016/j.lungcan.2025.108798
Published
2025 Nov
Container
Lung cancer (Amsterdam, Netherlands)
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.lungcan.2025.108798,
  title = {Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer Group.},
  author = {Brandão M and Prisciandaro E and Xenophontos E and Mariolo A and Sadeghi AH and Filippi AR and Levy A and Bandura A and Caramella C and Dickhoff C and de Margerie-Mellon C and Faivre-Finn C and Portik D and Sanchez-Lorente D and De Ruysscher D and Smit E and Gobbini E and Fadel E and Ruffini E and Olmetto E and Cortiula F and Bahce I and Houda I and Opitz I and Naidoo J and Edwards J and Remon J and Benitez JC and Trujillo JC and Derks J and Amrane K and Hartemink KJ and Stathopoulos K and Hendriks LEL and Iglesias M and Occhipinti M and Guckenberger M and Giaj Levra N and Girard N and Reguart N and Mercier O and Bironzo P and Hofman P and Petersen RH and De Angelis R and Abgral R and Terrisse S and Popat S and Pierret T and Blum TG and Ricardi U and Dionisi V and Berghmans T and Dingemans AC and European Organisation for Research, Treatment of Cancer EORTC Lung Cancer Group},
  year = {2025},
  journal = {Lung cancer (Amsterdam, Netherlands)},
  doi = {10.1016/j.lungcan.2025.108798},
  url = {https://doi.org/10.1016/j.lungcan.2025.108798}
}

RIS

TY  - JOUR
TI  - Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer Group.
AU  - Brandão M
AU  - Prisciandaro E
AU  - Xenophontos E
AU  - Mariolo A
AU  - Sadeghi AH
AU  - Filippi AR
AU  - Levy A
AU  - Bandura A
AU  - Caramella C
AU  - Dickhoff C
AU  - de Margerie-Mellon C
AU  - Faivre-Finn C
AU  - Portik D
AU  - Sanchez-Lorente D
AU  - De Ruysscher D
AU  - Smit E
AU  - Gobbini E
AU  - Fadel E
AU  - Ruffini E
AU  - Olmetto E
AU  - Cortiula F
AU  - Bahce I
AU  - Houda I
AU  - Opitz I
AU  - Naidoo J
AU  - Edwards J
AU  - Remon J
AU  - Benitez JC
AU  - Trujillo JC
AU  - Derks J
AU  - Amrane K
AU  - Hartemink KJ
AU  - Stathopoulos K
AU  - Hendriks LEL
AU  - Iglesias M
AU  - Occhipinti M
AU  - Guckenberger M
AU  - Giaj Levra N
AU  - Girard N
AU  - Reguart N
AU  - Mercier O
AU  - Bironzo P
AU  - Hofman P
AU  - Petersen RH
AU  - De Angelis R
AU  - Abgral R
AU  - Terrisse S
AU  - Popat S
AU  - Pierret T
AU  - Blum TG
AU  - Ricardi U
AU  - Dionisi V
AU  - Berghmans T
AU  - Dingemans AC
AU  - European Organisation for Research, Treatment of Cancer EORTC Lung Cancer Group
PY  - 2025
JO  - Lung cancer (Amsterdam, Netherlands)
DO  - 10.1016/j.lungcan.2025.108798
UR  - https://doi.org/10.1016/j.lungcan.2025.108798
ER  - 

APA

M, B., E, P., E, X., A, M., AH, S., AR, F., A, L., A, B., C, C., C, D., C, D. M., C, F., D, P., D, S., D, D. R., E, S., E, G., E, F., E, R., E, O., F, C., I, B., I, H., I, O., J, N., J, E., J, R., JC, B., JC, T., J, D., K, A., KJ, H., K, S., LEL, H., M, I., M, O., M, G., N, G. L., N, G., N, R., O, M., P, B., P, H., RH, P., R, D. A., R, A., S, T., S, P., T, P., TG, B., U, R., V, D., T, B., AC, D., & Group, E. O. F. R. T. O. C. E. L. C. (2025). Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer Group.. Lung cancer (Amsterdam, Netherlands). https://doi.org/10.1016/j.lungcan.2025.108798

Source records